Christopher Chen of the School of Engineering and Applied Science says it is rare when a researcher can combine medical expertise with technical application.
Penn in the News
Jack Guttentag of the Wharton School authors an op-ed on mortgage gouging.
Sanjeev Khanna of Computer and Information Systems and the School of Engineering and Applied Science is awarded a Guggenheim Fellowship.
Anthony Sorrentino of the Office of the Executive Vice President discusses development in Philadelphia.
Kathleen Hall Jamieson of the Annenberg School for Communication discusses the Don Imus controversy.
Theodore Hershberg of the School of Arts and Sciences says the School District of Philadelphia needs revamping.
Nathaniel Persily of the Law School says the rights of those in civil unions are still somewhat ambiguous.
Sean Hennessy of the School of Medicine says the FDA should focus more on post-approval safety funding.
Megan Mitchell of the Wharton School discusses business-school entrepreneurial competitions.
William Labov of the School of Arts and Sciences discusses the evolution of the English language.
Daniel Bogen of the School of Engineering and Applied Science discusses the “Taste of Judaism” program.
John Kucharczuk of the School of Medicine says a new stent treatment can help emphysema patients.
Dean Lee Stetson of Admissions discusses wait listing.
Joan Von Feldt of the School of Medicine says nutraceuticals do not have the same safety requirements and regulations as pharmaceuticals.
Benjamin Horton of the School of Arts and Sciences discusses local areas that are at risk due to climate shifts.
Peter Groeneveld of the School of Medicine and Penn researchers are cited for research on implantable cardioverter-defibrillators.
Michael Eric Dyson of the School of Arts and Sciences discusses presidential candidate Barack Obama's lack of commentary on the Imus controversy.
PennVention is featured.
Roger Greenberg of the School of Medicine discusses a finding that may reduce invasive treatments in women with breast cancer.
Mark Pauly of the Wharton School comments on an insurance-company merger.